Abbott Laboratories | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
EUR1.28 |
Market Cap |
EUR133.37 B |
Shares Outstanding |
1.75 B |
Public Float |
1.7 B |
Abbott Laboratories | |
Stock Exchange | Mexican Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
1.75 B |
Public Float |
1.7 B |
Abbott Laboratories | |
Stock Exchange | New York Stock Exchange |
EPS |
$1.48 |
Market Cap |
$150.7 B |
Shares Outstanding |
1.76 B |
Public Float |
1.74 B |
Abbott Laboratories | |
Stock Exchange | Santiago Stock Exchange |
EPS |
- |
Market Cap |
$84.27 B |
Shares Outstanding |
1.74 B |
Public Float |
1.7 B |
Address |
100 Abbott Park Road Abbott Park Illinois 60064 United States |
Employees | - |
Website | http://www.abbott.com |
Updated | 07/08/2019 |
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. |